Novel conservative management of chronic kidney disease via dialysis-free interventions

Diana Zarantonello, Connie M Rhee, Kamyar Kalantar-Zadeh, Giuliano Brunori, Diana Zarantonello, Connie M Rhee, Kamyar Kalantar-Zadeh, Giuliano Brunori

Abstract

Purpose of review: In advanced chronic kidney disease (CKD) patients with progressive uremia, dialysis has traditionally been the dominant treatment paradigm. However, there is increasing interest in conservative and preservative management of kidney function as alternative patient-centered treatment approaches in this population.

Recent findings: The primary objectives of conservative nondialytic management include optimization of quality of life and treating symptoms of end-stage renal disease (ESRD). Dietetic-nutritional therapy can be a cornerstone in the conservative management of CKD by reducing glomerular hyperfiltration, uremic toxin generation, metabolic acidosis, and phosphorus burden. Given the high symptom burden of advanced CKD patients, routine symptom assessment using validated tools should be an integral component of their treatment. As dialysis has variable effects in ameliorating symptoms, palliative care may be needed to manage symptoms such as pain, fatigue/lethargy, anorexia, and anxiety/depression. There are also emerging treatments that utilize intestinal (e.g., diarrhea induction, colonic dialysis, oral sorbents, gut microbiota modulation) and dermatologic pathways (e.g., perspiration reduction) to reduce uremic toxin burden.

Summary: As dialysis may not confer better survival nor improved patient-centered outcomes in certain patients, conservative management is a viable treatment option in the advanced CKD population.

References

    1. Davison SN, Levin A, Moss AH, et al. Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care. Kidney Int 2015; 88:447–459.
    1. Davison SN, Tupala B, Wasylynuk BA, et al. Recommendations for the care of patients receiving conservative kidney management: focus on management of CKD and symptoms. Clin J Am Soc Nephrol 2019; 14:626–634.
    1. Kalantar-Zadeh K, Wightman A, Liao S. Ensuring choice for people with kidney failure – dialysis, supportive care, and hope. N Engl J Med 2020; 383:99.
    1. Rhee CM, Nguyen DV, Nyamathi A, Kalantar-Zadeh K. Conservative vs. preservative management of chronic kidney disease: similarities and distinctions. Curr Opin Nephrol Hypertens 2020; 29:92–102.
    1. Chandna SM, Da Silva-Gane M, Marshall C, et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 2011; 26:1608–1614.
    1. Hussain JA, Mooney A, Russon L. Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med 2013; 27:829–839.
    1. Murtagh FE, Marsh JE, Donohoe P, et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007; 22:1955–1962.
    1. Verberne WR, Geers AB, Jellema WT, et al. Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis. Clin J Am Soc Nephrol 2016; 11:633–640.
    1. Bellizzi V, Cupisti A, Locatelli F, et al. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrol 2016; 17:77.
    1. Brunori G, Viola BF, Maiorca P, Cancarini G. How to manage elderly patients with chronic renal failure: conservative management versus dialysis. Blood Purif 2008; 26:36–40.
    1. Cupisti A, Brunori G, Di Iorio BR, et al. Nutritional treatment of advanced CKD: twenty consensus statements. J Nephrol 2018; 31:457–473.
    1. Kalantar-Zadeh K, Joshi S, Schlueter R, et al. Plant-dominant low-protein diet for conservative management of chronic kidney disease. Nutrients 2020; 12:1931.
    1. Cabrera VJ, Hansson J, Kliger AS, Finkelstein FO. Symptom management of the patient with CKD: the role of dialysis. Clin J Am Soc Nephrol 2017; 12:687–693.
    1. Flythe JE, Hilliard T, Lumby E, et al. Fostering innovation in symptom management among hemodialysis patients: paths forward for insomnia, muscle cramps, and fatigue. Clin J Am Soc Nephrol 2019; 14:150–160.
    1. Gelfand SL, Scherer JS, Koncicki HM. Kidney supportive care: core curriculum 2020. Am J Kidney Dis 2020; 75:793–806.
    1. Scherer JS, Combs SA, Brennan F. Sleep disorders, restless legs syndrome, and uremic pruritus: diagnosis and treatment of common symptoms in dialysis patients. Am J Kidney Dis 2017; 69:117–128.
    1. Davison SN. Conservative kidney management: caring for patients unlikely to benefit from dialysis. Am J Kidney Dis 2020; 75:153–154.
    1. Keller RW Jr, Kopple JD, Kalantar-Zadeh K. Perspiration interventions for conservative management of kidney disease and uremia. Curr Opin Nephrol Hypertens 2020; 29:57–63.
    1. Puri I, Shirazi NM, Yap E, Saggi SJ. Intestinal dialysis for conservative management of uremia. Curr Opin Nephrol Hypertens 2020; 29:64–70.
    1. Munshi SK, Vijayakumar N, Taub NA, et al. Outcome of renal replacement therapy in the very elderly. Nephrol Dial Transplant 2001; 16:128–133.
    1. Song MK. Quality of life of patients with advanced chronic kidney disease receiving conservative care without dialysis. Semin Dial 2016; 29:165–169.
    1. Brown MA, Collett GK, Josland EA, et al. CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life. Clin J Am Soc Nephrol 2015; 10:260–268.
    1. Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 2009; 4:1611–1619.
    1. Da Silva-Gane M, Wellsted D, Greenshields H, et al. Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol 2012; 7:2002–2009.
    1. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003; 14:1012–1021.
    1. Kurella Tamura M, Desai M, Kapphahn KI, et al. Dialysis versus medical management at different ages and levels of kidney function in veterans with advanced CKD. J Am Soc Nephrol 2018; 29:2169–2177.
    1. Morton RL, Turner RM, Howard K, et al. Patients who plan for conservative care rather than dialysis: a national observational study in Australia. Am J Kidney Dis 2012; 59:419–427.
    1. Seow YY, Cheung YB, Qu LM, Yee AC. Trajectory of quality of life for poor prognosis stage 5D chronic kidney disease with and without dialysis. Am J Nephrol 2013; 37:231–238.
    1. Shum CK, Tam KF, Chak WL, et al. Outcomes in older adults with stage 5 chronic kidney disease: comparison of peritoneal dialysis and conservative management. J Gerontol A Biol Sci Med Sci 2014; 69:308–314.
    1. Teruel JL, Burguera Vion V, Gomis Couto A, et al. Choosing conservative therapy in chronic kidney disease. Nefrologia 2015; 35:273–279.
    1. Verberne WR, van den Wittenboer ID, Voorend CGN, et al. Health-related quality of life and symptoms of conservative care versus dialysis in patients with end-stage kidney disease: a systematic review. Nephrol Dial Transplant 2020; [Epub ahead of print].
    1. Rhee CM, Ghahremani-Ghajar M, Obi Y, Kalantar-Zadeh K. Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management. Panminerva Med 2017; 59:188–196.
    1. Rhee CM, Unruh M, Chen J, et al. Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 2013; 26:720–727.
    1. Bargman JM, Thorpe KE, Churchill DN. CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158–2162.
    1. Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 2016; 90:262–271.
    1. Obi Y, Rhee CM, Mathew AT, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol 2016; 27:3758–3768.
    1. Shafi T, Jaar BG, Plantinga LC, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 2010; 56:348–358.
    1. Kalantar-Zadeh K, Wightman A, Liao S. Ensuring choice for people with kidney failure - dialysis, supportive care, and hope. N Engl J Med 2020; 383:99.
    1. Kramer H. Diet and chronic kidney disease. Adv Nutr 2019; 10:S367–S379.
    1. Rhee CM, Ahmadi SF, Kovesdy CP, Kalantar-Zadeh K. Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials. J Cachexia Sarcopenia Muscle 2018; 9:235–245.
    1. Di Micco L, Di Lullo L, Bellasi A, Di Iorio BR. Very low protein diet for patients with chronic kidney disease: recent insights. J Clin Med 2019; 8:718.
    1. Kalantar-Zadeh K, Moore LW. Does kidney longevity mean healthy vegan food and less meat or is any low-protein diet good enough? J Ren Nutr 2019; 29:79–81.
    1. Joshi S, Hashmi S, Shah S, Kalantar-Zadeh K. Plant-based diets for prevention and management of chronic kidney disease. Curr Opin Nephrol Hypertens 2020; 29:16–21.
    1. Mirmiran P, Yuzbashian E, Aghayan M, et al. A prospective study of dietary meat intake and risk of incident chronic kidney disease. J Ren Nutr 2020; 30:111–118.
    1. Carrero JJ, Gonzalez-Ortiz A, Avesani CM, et al. Plant-based diets to manage the risks and complications of chronic kidney disease. Nat Rev Nephrol 2020; 16:525–542.
    1. Chen X, Wei G, Jalili T, et al. The associations of plant protein intake with all-cause mortality in CKD. Am J Kidney Dis 2016; 67:423–430.
    1. Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian-vegan diets. Nutrients 2020; 12:779.
    1. Joshi S, Shah S, Kalantar-Zadeh K. Adequacy of plant-based proteins in chronic kidney disease. J Ren Nutr 2019; 29:112–117.
    1. Rose SD, Strombom A. A plant-based diet prevents and treats chronic kidney disease. JOJ Urol Nephrol 2019; 6:555687.
    1. Adair KE, Bowden RG. Ameliorating chronic kidney disease using a whole food plant-based diet. Nutrients 2020; 12:1007.
    1. Cases A, Cigarran-Guldris S, Mas S, Gonzalez-Parra E. Vegetable-based diets for chronic kidney disease? It is time to reconsider. Nutrients 2019; 11:1263.
    1. Chauveau P, Koppe L, Combe C, et al. Vegetarian diets and chronic kidney disease. Nephrol Dial Transplant 2019; 34:199–207.
    1. Clegg DJ, Hill Gallant KM. Plant-based diets in CKD. Clin J Am Soc Nephrol 2019; 14:141–143.
    1. Kim H, Caulfield LE, Garcia-Larsen V, et al. Plant-based diets and incident CKD and kidney function. Clin J Am Soc Nephrol 2019; 14:682–691.
    1. Liu HW, Tsai WH, Liu JS, Kuo KL. Association of vegetarian diet with chronic kidney disease. Nutrients 2019; 11:279.
    1. Mozaffari H, Ajabshir S, Alizadeh S. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: a systematic review and meta-analysis of observational studies. Clin Nutr 2020; 39:2035–2044.
    1. Taghavi M, Sadeghi A, Maleki V, et al. Adherence to the dietary approaches to stop hypertension-style diet is inversely associated with chronic kidney disease: a systematic review and meta-analysis of prospective cohort studies. Nutr Res 2019; 72:46–56.
    1. Goraya N, Wesson DE. Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2019; 28:267–277.
    1. Gonzalez-Ortiz A, Xu H, Avesani CM, et al. Plant-based diets, insulin sensitivity and inflammation in elderly men with chronic kidney disease. J Nephrol 2020; 33:1091–1101.
    1. Toba K, Hosojima M, Kabasawa H, et al. Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease. BMC Nephrol 2019; 20:421.
    1. Di Iorio BR, Rocchetti MT, De Angelis M, et al. Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (Medika Study). J Clin Med 2019; 8:1424.
    1. Camerotto C, Cupisti A, D’Alessandro C, et al. Dietary fiber and gut microbiota in renal diets. Nutrients 2019; 11:2149.
    1. D’Alessandro C, Cumetti A, Pardini E, et al. Prevalence and correlates of hyperkalemia in a renal nutrition clinic. Intern Emerg Med 2020; [Epub ahead of print].
    1. Garibotto G, Picciotto D, Saio M, et al. Muscle protein turnover and low-protein diets in patients with chronic kidney disease. Nephrol Dial Transplant 2020; 35:741–751.
    1. Flythe JE, Powell JD, Poulton CJ, et al. Patient-reported outcome instruments for physical symptoms among patients receiving maintenance dialysis: a systematic review. Am J Kidney Dis 2015; 66:1033–1046.
    1. Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 2009; 4:1057–1064.
    1. Kopple JD, Shapiro BB, Feroze U, et al. Hemodialysis treatment engenders anxiety and emotional distress. Clin Nephrol 2017; 88:205–217.
    1. WHO definition of palliative care. . [Accessed 20 August 2020].
    1. Dai S, Dai Y, Peng J, et al. Simplified colonic dialysis with hemodialysis solutions delays the progression of chronic kidney disease. QJM 2019; 112:189–196.
    1. Asai M, Kumakura S, Kikuchi M. Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients. Ren Fail 2019; 41:47–56.
    1. Chen YC, Wu MY, Hu PJ, et al. Effects and safety of an oral adsorbent on chronic kidney disease progression: a systematic review and meta-analysis. J Clin Med 2019; 8:1718.
    1. Cupisti A, Piccoli GB, Gallieni M. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2020; 29:71–79.
    1. Gao Y, Wang G, Li Y, et al. Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3–4 chronic kidney disease. J Nephrol 2019; 32:265–272.
    1. Chen W, Abramowitz MK. Advances in management of chronic metabolic acidosis in chronic kidney disease. Curr Opin Nephrol Hypertens 2019; 28:409–416.
    1. Palmer BF. Potassium binders for hyperkalemia in chronic kidney disease-diet, renin–angiotensin–aldosterone system inhibitor therapy, and hemodialysis. Mayo Clin Proc 2020; 95:339–354.
    1. Sussman EJ, Singh B, Clegg D, et al. Let them eat healthy: can emerging potassium binders help overcome dietary potassium restrictions in chronic kidney disease? J Ren Nutr 2020; S1051-2276(20)30025-X.
    1. Zheng HJ, Guo J, Wang Q, et al. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2020; 1–22.
    1. Ramos CI, Armani RG, Canziani MEF, et al. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant 2019; 34:1876–1884.
    1. Hill E, Sapa H, Negrea L, et al. Effect of oat beta-glucan supplementation on chronic kidney disease: a feasibility study. J Ren Nutr 2020; 30:208–215.
    1. Lai S, Molfino A, Testorio M, et al. Effect of low-protein diet and inulin on microbiota and clinical parameters in patients with chronic kidney disease. Nutrients 2019; 11:3006.
    1. Vitetta L, Llewellyn H, Oldfield D. Gut dysbiosis and the intestinal microbiome: Streptococcus thermophilus a key probiotic for reducing uremia. Microorganisms 2019; 7.

Source: PubMed

3
Abonnieren